Literature DB >> 11243968

Smoking, respiratory symptoms, and diseases : a comparative study between northern Sweden and northern Finland: report from the FinEsS study.

M Lindström1, J Kotaniemi, E Jönsson, B Lundbäck.   

Abstract

STUDY
OBJECTIVES: The influences of different smoking categories on the prevalence of respiratory symptoms, asthma, and chronic bronchitis have been examined in the most northern province of Sweden, Norrbotten, and in Lapland, Finland. The two areas have similar geographic and demographic conditions. METHODS AND STUDY POPULATION: The study is a part of the FinEsS studies, which are epidemiologic respiratory surveys in progress in Sweden, Finland, and Estonia. A random sample of 20- to 69-years-olds were invited to answer a postal questionnaire about respiratory symptoms, smoking habits, and occupation. In Norrbotten, 8,333 subjects were invited and 7,104 responded (85%). In Lapland, 8,005 were invited and 6,633 responded (83%).
RESULTS: The participation by age and sex was similar in both countries. The prevalence of smokers in Lapland was 32% vs 26% in Norrbotten. Significantly more women than men in Norrbotten were smokers, while the opposite was true for Lapland. Sputum production was the most prevalent symptom in both areas, 25% in Lapland vs 19% in Norrbotten. The prevalence of chronic productive cough was 11% in Lapland and 7% in Norrbotten. Bronchitic symptoms were more prevalent in Lapland among both smokers and nonsmokers. A positive family history of chronic obstructive airway disease together with increased number of consumed cigarettes showed an additive effect for both chronic productive cough and wheezing. The odds ratio (OR) for wheezing during the last 12 months was 3.8 for subjects without a family history of obstructive airway disease who consumed > 14 cigarettes per day compared with nonsmokers, but if the subjects had a family history of obstructive airway disease, the risk for wheezing increased to OR 8.4.
CONCLUSION: Bronchitic symptoms were more common in Finland. The difference remained also after correction for demographic variables including smoking habits, age and socioeconomic group, and family history of obstructive airway disease. Identical methods, sample composition, and the high participation rate contribute to the validity of the results. Air pollution, including environmental tobacco smoke, may contribute to the difference. To explain the difference, further analysis and investigations of social and environmental factors as well as genetic factors are needed.

Entities:  

Mesh:

Year:  2001        PMID: 11243968     DOI: 10.1378/chest.119.3.852

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  19 in total

1.  Modification of gene expression of the small airway epithelium in response to cigarette smoking.

Authors:  Ben-Gary Harvey; Adriana Heguy; Philip L Leopold; Brendan J Carolan; Barbara Ferris; Ronald G Crystal
Journal:  J Mol Med (Berl)       Date:  2006-11-08       Impact factor: 4.599

2.  Predictors of dyspnoea prevalence: results from the BOLD study.

Authors:  Rune Grønseth; William M Vollmer; Jon A Hardie; Inga Sif Ólafsdóttir; Bernd Lamprecht; A Sonia Buist; Louisa Gnatiuc; Amund Gulsvik; Ane Johannessen; Paul Enright
Journal:  Eur Respir J       Date:  2013-10-31       Impact factor: 16.671

Review 3.  Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema.

Authors:  Barbara A Forey; Alison J Thornton; Peter N Lee
Journal:  BMC Pulm Med       Date:  2011-06-14       Impact factor: 3.317

4.  Decline in air pollution and change in prevalence in respiratory symptoms and chronic obstructive pulmonary disease in elderly women.

Authors:  Tamara Schikowski; Ulrich Ranft; Dorothee Sugiri; Andrea Vierkötter; Thomas Brüning; Volker Harth; Ursula Krämer
Journal:  Respir Res       Date:  2010-08-22

5.  What are the Differences Between Smoker and Non-smoker COPD Cases? Is it a Different Phenotype?

Authors:  Filiz Güldaval; Gülru Polat; Sibel Doruk; Gülistan Karadeniz; Aysu Ayranci; Merve Türk; Mine Gayaf; Melike Yüksel Yavuz; Melih Büyükşirin; Ceyda Anar
Journal:  Turk Thorac J       Date:  2021-07

6.  Up-to-date on mortality in COPD - report from the OLIN COPD study.

Authors:  Anne Lindberg; Lars-Gunnar Larsson; Hana Muellerova; Eva Rönmark; Bo Lundbäck
Journal:  BMC Pulm Med       Date:  2012-01-09       Impact factor: 3.317

7.  Prevalence trends in respiratory symptoms and asthma in relation to smoking - two cross-sectional studies ten years apart among adults in northern Sweden.

Authors:  Helena Backman; Linnea Hedman; Sven-Arne Jansson; Anne Lindberg; Bo Lundbäck; Eva Rönmark
Journal:  World Allergy Organ J       Date:  2014-01-02       Impact factor: 4.084

8.  COPD in Nonsmokers: Reports from the Tunisian Population-Based Burden of Obstructive Lung Disease Study.

Authors:  Meriam Denguezli; Hager Daldoul; Imed Harrabi; Louisa Gnatiuc; Sonia Coton; Peter Burney; Zouhair Tabka
Journal:  PLoS One       Date:  2016-03-24       Impact factor: 3.240

9.  Environmental exposure as an independent risk factor of chronic bronchitis in northwest Russia.

Authors:  Pentti Nieminen; Dmitry Panychev; Sergei Lyalyushkin; German Komarov; Alexander Nikanov; Mark Borisenko; Vuokko L Kinnula; Tuula Toljamo
Journal:  Int J Circumpolar Health       Date:  2013-02-22       Impact factor: 1.228

10.  Cigarette smoking and dyspnea perception.

Authors:  Elisabetta Rosi; Giorgio Scano
Journal:  Tob Induc Dis       Date:  2004-03-15       Impact factor: 2.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.